QUOTE AND NEWS
newratings.com  Apr 14  Comment 
WASHINGTON (dpa-AFX) - Synta Pharmaceuticals Corp. (SNTA) and private firm Madrigal Pharmaceuticals, Inc. Thursday announced a definitive merger agreement under which Madrigal will merge with a wholly-owned subsidiary of Synta in an all-stock...
FierceBiotech  Oct 21  Comment 
Synta Pharmaceuticals stopped a Phase III trial on a lung cancer drug after investigators realized it was unlikely to meet its goals, news that plunged the biotech into penny-stock territory as management tries to figure out a way forward.
newratings.com  Oct 21  Comment 
JERUSALEM (dpa-AFX) - Corbus Pharmaceuticals Holdings Inc.'s (CRBP) investigational new drug Resunab for the treatment of cystic fibrosis has been designated as a Fast Track development program and granted Orphan Drug Designation. The...
Benzinga  Oct 21  Comment 
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company has decided to terminate the Phase 3 GALAXY-2 trial of ganetespib and docetaxel in the second-line treatment of patients with advanced non-small cell...





You may also be interested in articles related to Synta Pharmaceuticals (SNTA):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki